US2014235832A1PendingUtilityA1
Rank ligand polypeptides
Est. expiryDec 23, 2016(expired)· nominal 20-yr term from priority
Inventors:Dirk M. Anderson
A61P 43/00A61P 37/02A61P 35/00A61P 37/00C12Q 1/6876A61P 29/00C07K 2319/32C07K 14/525C07K 2319/30C07K 14/7151C07K 14/70575C07K 14/70578A61K 38/00C07K 16/241C07K 2319/02C07K 14/435C07K 2319/00C07K 2319/73C07K 2317/76C07K 16/2875C07K 2317/73C07K 14/52
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are kits for use in detecting RANKL polypeptides.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A kit for detecting RANKL protein, said kit comprising a RANKL polypeptide selected from the group consisting of:
a) a polypeptide comprising amino acids 1-317 of SEQ ID NO:13; b) a polypeptide comprising amino acids 69-313 of SEQ ID NO:13; c) a polypeptide comprising amino acids 162-313 of SEQ ID NO:13 d) a polypeptide comprising amino acids 138-317 of SEQ ID NO:13; e) a polypeptide comprising amino acids x to y of SEQ ID NO:13, wherein x is an amino terminal amino acid between 69 and 162 of SEQ ID NO:13, and y is a carboxy terminal amino acid between 313 and 317 of SEQ ID NO:13; and f) a polypeptide having an at least 90% amino acid sequence identity with a polypeptide comprising amino acids 162-317 of SEQ ID NO:13.
2 . A kit according to claim 1 , said kit further comprising a monoclonal antibody that binds specifically to a RANKL polypeptide consisting of amino acids 1-317 of SEQ ID NO:13.
3 . A kit according to claim 1 , wherein said kit is used with an assay format selected from the group consisting of ELISA and a solid phase binding assay.
4 . A kit according to claim 1 , wherein said detected RANKL protein is from a patient specimen.
5 . A kit for detecting the presence of human RANKL nucleic acid in an in vitro assay, said kit comprising at least one fragment of DNA that comprises at least 17 nucleotides of SEQ ID NO:12 or that comprises at least 17 nucleotides complementary to SEQ ID NO:12.
6 . A kit according to claim 5 , wherein the detection method is polymerase chain reaction and the kit comprises a first fragment of DNA comprising at least 17 nucleotides of SEQ ID NO:12 and a second fragment of DNA comprising at least 17 nucleotides complementary to SEQ ID NO:12.
7 . A kit according to claim 5 , wherein the detection method is Northern blot or Southern blot.
8 . A kit according to claim 5 , wherein said detected human RANKL nucleic acid is from a patient specimen.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.